{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:31:20Z","timestamp":1793039480026,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00383-017-4189-x","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T06:15:37Z","timestamp":1507616137000},"page":"195-201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Invariant natural killer T infiltration in neuroblastoma with favorable outcome"],"prefix":"10.1007","volume":"34","author":[{"given":"Tomoro","family":"Hishiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Mise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumie","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Takami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Terui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyuki","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugo","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Motohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"4189_CR1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0046-8177(74)80021-3","volume":"5","author":"RP Bolande","year":"1974","unstructured":"Bolande RP (1974) The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 5:409\u2013429","journal-title":"Hum Pathol"},{"key":"4189_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S1470-2045(13)70309-7","volume":"14","author":"SG Kreissman","year":"2013","unstructured":"Kreissman SG, Seeger RC, Matthay KK, London WB, Sposto R, Grupp SA, Haas-Kogan DA, LaQuaglia MP, Yu AL, Diller L, Buxton A, Park JR, Cohn SL, Maris JM, Reynolds CP, Villablanca JG (2013) Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol 14:999\u20131008. doi:\n10.1016\/S1470-2045(13)70309-7","journal-title":"Lancet Oncol"},{"key":"4189_CR3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1470-2045(08)70069-X","volume":"9","author":"AD Pearson","year":"2008","unstructured":"Pearson AD, Pinkerton CR, Lewis IJ, Imeson J, Ellershaw C, Machin D (2008) High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncol 9:247\u2013256","journal-title":"Lancet Oncol"},{"issue":"17","key":"4189_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(17)30070-0","volume":"18","author":"R Ladenstein","year":"2017","unstructured":"Ladenstein R, P\u00f6tschger U, Pearson AD, Brock P, Luksch R, Castel V, Yaniv I, Papadakis V, Laureys G, Malis J, Balwierz W, Ruud E, Kogner P, Schroeder H, de Lacerda AF, Beck-Popovic M, Bician P, Garami M, Trahair T, Canete A, Ambros PF, Holmes K, Gaze M, Schreier G, Garaventa A, Vassal G, Michon J, Valteau-Couanet D, SIOP Europe Neuroblastoma Group (SIOPEN) (2017) Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1\/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial. Lancet Oncol 18:500\u2013514. S1470-2045 (17)30070\u20130. doi:\n10.1016\/S1470-2045(17)30070-0","journal-title":"Lancet Oncol"},{"key":"4189_CR5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1200\/JCO.2011.37.9990","volume":"30","author":"DR Strother","year":"2012","unstructured":"Strother DR, London WB, Schmidt ML, Brodeur GM, Shimada H, Thorner P, Collins MH, Tagge E, Adkins S, Reynolds CP, Murray K, Lavey RS, Matthay KK, Castleberry R, Maris JM, Cohn SL (2012) Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children\u2019s Oncology Group study P9641. J Clin Oncol 30:1842\u20131848","journal-title":"J Clin Oncol"},{"key":"4189_CR6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjc.6604640","volume":"99","author":"B Bernardi De","year":"2008","unstructured":"De Bernardi B, Mosseri V, Rubie H, Castel V, Foot A, Ladenstein R, Laureys G, Beck-Popovic M, de Lacerda AF, Pearson AD, De Kraker J, Ambros PF, de Rycke Y, Conte M, Bruzzi P, Michon J, SIOP Europe Neuroblastoma Group (2008) Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer 99:1027\u20131033","journal-title":"Br J Cancer"},{"key":"4189_CR7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/SLA.0b013e31826cbbbd","volume":"256","author":"JG Nuchtern","year":"2012","unstructured":"Nuchtern JG, London WB, Barnewolt CE, Naranjo A, McGrady PW, Geiger JD, Diller L, Schmidt ML, Maris JM, Cohn SL, Shamberger RC (2012) A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children\u2019s Oncology Group study. Ann Surg 256:573\u2013580","journal-title":"Ann Surg"},{"key":"4189_CR8","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1200\/JCO.2007.12.3349","volume":"26","author":"B Hero","year":"2008","unstructured":"Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F (2008) Localized infant neuroblastomas often show spontaneous regression: Results of the prospective trials NB95-S and NB97. J Clin Oncol 26:1504\u20131510","journal-title":"J Clin Oncol"},{"key":"4189_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/bjc.1972.43","volume":"26","author":"I Lauder","year":"1972","unstructured":"Lauder I, Aherne W (1972) The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer 26:321\u2013330","journal-title":"Br J Cancer"},{"key":"4189_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-3468(68)91005-1","volume":"3","author":"RF Martin","year":"1968","unstructured":"Martin RF, Beckwith JB (1968) Lymphoid infiltrates in neuroblastomas: Their occurrence and prognostic significance. J Pediatr Surg 3:161\u2013164","journal-title":"J Pediatr Surg"},{"key":"4189_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-200007000-00007","volume":"22","author":"NL Antunes","year":"2000","unstructured":"Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, Abrey LE, Dalmau J (2000) Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 22:315\u2013320","journal-title":"J Pediatr Hematol Oncol"},{"key":"4189_CR12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3835(93)90182-9","volume":"73","author":"Y Kataoka","year":"1993","unstructured":"Kataoka Y, Matsumura T, Yamamoto S, Sugimoto T, Sawada T (1993) Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma. Cancer Lett 73:11\u201321","journal-title":"Cancer Lett"},{"key":"4189_CR13","first-page":"362","volume":"56","author":"D Valteau","year":"1996","unstructured":"Valteau D, Scott V, Carcelain G, Hartmann O, Escudier B, Hercend T, Triebel F (1996) T-cell receptor repertoire in neuroblastoma patients. Cancer Res 56:362\u2013369","journal-title":"Cancer Res"},{"key":"4189_CR14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s002620050267","volume":"42","author":"P Facchetti","year":"1996","unstructured":"Facchetti P, Prigione I, Ghiotto F, Tasso P, Garaventa A, Pistoia V (1996) Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma. Cancer Immunol Immunother 42:170\u2013178","journal-title":"Cancer Immunol Immunother"},{"key":"4189_CR15","doi-asserted-by":"crossref","first-page":"e1019981","DOI":"10.1080\/2162402X.2015.1019981","volume":"4","author":"M Mina","year":"2015","unstructured":"Mina M, Boldrini R, Citti A, Romania P, D\u2019Alicandro V, De Ioris M, Castellano A, Furlanello C, Locatelli F, Fruci D (2015) Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma. Oncoimmunology 4:e1019981","journal-title":"Oncoimmunology"},{"key":"4189_CR16","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","volume":"278","author":"T Kawano","year":"1997","unstructured":"Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M (1997) CD1d-restricted and TCR-mediated activation of V\u03b114 NKT cells by glycosylceramides. Science 278:1626\u20131629","journal-title":"Science"},{"key":"4189_CR17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20031462","volume":"199","author":"LS Metelitsa","year":"2004","unstructured":"Metelitsa LS, Wu HW, Wang H, Yang Y, Warsi Z, Asgharzadeh S, Groshen S, Wilson SB, Seeger RC (2004) Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J Exp Med 199:1213\u20131221","journal-title":"J Exp Med"},{"key":"4189_CR18","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1158\/1078-0432.CCR-05-0877","volume":"11","author":"T Tachibana","year":"2005","unstructured":"Tachibana T, Onodera H, Tsuruyama T, Mori A, Nagayama S, Hiai H, Imamura M (2005) Increased intratumor V\u03b124-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res 11:7322\u20137327","journal-title":"Clin Cancer Res"},{"key":"4189_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10875-012-9697-9","volume":"32","author":"K Nagato","year":"2012","unstructured":"Nagato K, Motohashi S, Ishibashi F, Okita K, Yamasaki K, Moriya Y, Hoshino H, Yoshida S, Hanaoka H, Fujii S, Taniguchi M, Yoshino I, Nakayama T (2012) Accumulation of activated invariant natural killer T cells in the tumor microenvironment after \u03b1-galactosylceramide-pulsed antigen presenting cells. J Clin Immunol 32:1071\u20131081. doi:\n10.1007\/s10875-012-9697-9","journal-title":"J Clin Immunol"},{"key":"4189_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cas.12882","volume":"107","author":"N Mise","year":"2016","unstructured":"Mise N, Takami M, Suzuki A, Kamata T, Harada K, Hishiki T, Saito T, Terui K, Mitsunaga T, Nakata M, Ikeuchi T, Nakayama T, Yoshida H, Motohashi S (2016) Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells. Cancer Sci 107:233\u2013241. doi:\n10.1111\/cas.12882","journal-title":"Cancer Sci"},{"key":"4189_CR21","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jpedsurg.2010.08.021","volume":"45","author":"T Hishiki","year":"2010","unstructured":"Hishiki T, Saito T, Terui K, Sato Y, Takenouchi A, Yahata E, Ono S, Nakagawara A, Kamijo T, Nakamura Y, Matsunaga T, Yoshida H (2010) Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis\u2014a study of 106 primary neuroblastomas treated in a single institute. J Pediatr Surg 45:2293\u20132298. doi:\n10.1016\/j.jpedsurg.2010.08.021","journal-title":"J Pediatr Surg"},{"key":"4189_CR22","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1200\/JCO.2005.02.014","volume":"23","author":"T Gotoh","year":"2005","unstructured":"Gotoh T, Hosoi H, Iehara T, Kuwahara Y, Osone S, Tsuchiya K, Ohira M, Nakagawara A, Kuroda H, Sugimoto T (2005) Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncol 23:5205\u20135210","journal-title":"J Clin Oncol"},{"key":"4189_CR23","first-page":"15965","volume":"102","author":"S Motohashi","year":"2005","unstructured":"Motohashi S, Kobayashi S, Ito T, Magara KK, Mikuni O, Kamada N, Iizasa T, Nakayama T, Fujisawa T, Taniguchi M (2005) Preserved IFN-\u03b1 production of circulating V\u03b124 NKT cells in primary lung cancer patients. Int J Cancer 102:159\u201365","journal-title":"Int J Cancer"},{"key":"4189_CR24","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.7314\/APJCP.2012.13.11.5909","volume":"13","author":"CL Guo","year":"2012","unstructured":"Guo CL, Yang HC, Yang XH, Cheng W, Dong TX, Zhu WJ, Xu Z, Zhao L (2012) Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma. Asian Pac J Cancer Prev 13:5909\u20135913","journal-title":"Asian Pac J Cancer Prev"},{"key":"4189_CR25","doi-asserted-by":"publisher","first-page":"e0156497","DOI":"10.1371\/journal.pone.0156497","volume":"11","author":"S Lundgren","year":"2016","unstructured":"Lundgren S, Warfvinge CF, Elebro J, Heby M, Nodin B, Krzyzanowska A, Bjartell A, Leandersson K, Eberhard J, Jirstr\u00f6m K (2016) The prognostic impact of NK\/NKT cell density in periampullary adenocarcinoma differs by morphological type and adjuvant treatment. PLoS One 11:e0156497. doi:\n10.1371\/journal.pone.0156497","journal-title":"PLoS One"},{"issue":"7708","key":"4189_CR26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(71)91606-0","volume":"1","author":"GJ D\u2019Angio","year":"1971","unstructured":"D\u2019Angio GJ, Evans AE, Koop CE (1971) Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1(7708):1046\u20131049","journal-title":"Lancet"},{"key":"4189_CR27","first-page":"49","volume":"44","author":"AE Evans","year":"1976","unstructured":"Evans AE, Gerson J, Schnaufer L (1976) Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44:49\u201354","journal-title":"Natl Cancer Inst Monogr"},{"key":"4189_CR28","doi-asserted-by":"publisher","first-page":"70413","DOI":"10.1038\/nrclinonc.2014.168","volume":"11","author":"GM Brodeur","year":"2014","unstructured":"Brodeur GM, Bagatell R (2014) Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol. 11:704\u201313. doi:\n10.1038\/nrclinonc.2014.168","journal-title":"Nat Rev Clin Oncol"},{"key":"4189_CR29","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1200\/JCO.1998.16.4.1265","volume":"16","author":"K Yamamoto","year":"1998","unstructured":"Yamamoto K, Hanada R, Kikuchi A, Ichikawa M, Aihara T, Oguma E, Moritani T, Shimanuki Y, Tanimura M, Hayashi Y (1998) Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 16:1265\u20131269","journal-title":"J Clin Oncol"},{"key":"4189_CR30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/02841869009090048","volume":"29","author":"GB Challis","year":"1990","unstructured":"Challis GB, Stam HJ (1990) The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol 29:545\u2013550","journal-title":"Acta Oncol"},{"key":"4189_CR31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1749-6632.1964.tb40991.x","volume":"114","author":"TC Everson","year":"1964","unstructured":"Everson TC (1964) Spontaneous regression of cancer. Ann N Y Acad Sci 114:721\u2013735","journal-title":"Ann N Y Acad Sci"},{"key":"4189_CR32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM199303253281205","volume":"328","author":"A Nakagawara","year":"1993","unstructured":"Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847\u2013854","journal-title":"N Engl J Med"},{"key":"4189_CR33","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/onc.2010.13","volume":"29","author":"D Goldschneider","year":"2010","unstructured":"Goldschneider D, Mehlen P (2010) Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29:1865\u20131882. doi:\n10.1038\/onc.2010.13","journal-title":"Oncogene"},{"key":"4189_CR34","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ijc.28096","volume":"133","author":"KW Pajtler","year":"1993","unstructured":"Pajtler KW, Rebmann V, Lindemann M, Schulte JH, Schulte S, Stauder M, Leuschner I, Schmid KW, K\u00f6hl U, Schramm A, Eggert A (1993) Expression of NTRK1\/TrkA affects immunogenicity of neuroblastoma cells. Int J Cancer 133:908\u2013919. doi:\n10.1002\/ijc.28096","journal-title":"Int J Cancer"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-017-4189-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-017-4189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-017-4189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T08:52:05Z","timestamp":1517302325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-017-4189-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4189"],"URL":"https:\/\/doi.org\/10.1007\/s00383-017-4189-x","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}